BioAlliance Pharma Provides Updates On Its Major Achievements And Reports 2013 Consolidated Financial Results

Regulatory News :

BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products, today published its 2013 financial results, major achievements on its clinical programs in 2013 and its prospects 2014.

Help employers find you! Check out all the jobs and post your resume.